1. Home
  2. ANIP vs HP Comparison

ANIP vs HP Comparison

Compare ANIP & HP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • HP
  • Stock Information
  • Founded
  • ANIP 2001
  • HP 1920
  • Country
  • ANIP United States
  • HP United States
  • Employees
  • ANIP N/A
  • HP N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • HP Oil & Gas Production
  • Sector
  • ANIP Health Care
  • HP Energy
  • Exchange
  • ANIP Nasdaq
  • HP Nasdaq
  • Market Cap
  • ANIP 1.4B
  • HP 1.5B
  • IPO Year
  • ANIP N/A
  • HP N/A
  • Fundamental
  • Price
  • ANIP $64.03
  • HP $16.47
  • Analyst Decision
  • ANIP Strong Buy
  • HP Hold
  • Analyst Count
  • ANIP 9
  • HP 10
  • Target Price
  • ANIP $80.56
  • HP $22.78
  • AVG Volume (30 Days)
  • ANIP 303.6K
  • HP 1.8M
  • Earning Date
  • ANIP 08-05-2025
  • HP 08-06-2025
  • Dividend Yield
  • ANIP N/A
  • HP 6.07%
  • EPS Growth
  • ANIP N/A
  • HP N/A
  • EPS
  • ANIP N/A
  • HP 2.20
  • Revenue
  • ANIP $674,068,000.00
  • HP $3,084,858,000.00
  • Revenue This Year
  • ANIP $30.84
  • HP $36.76
  • Revenue Next Year
  • ANIP $7.39
  • HP $4.08
  • P/E Ratio
  • ANIP N/A
  • HP $7.50
  • Revenue Growth
  • ANIP 30.27
  • HP 12.23
  • 52 Week Low
  • ANIP $52.50
  • HP $14.65
  • 52 Week High
  • ANIP $77.00
  • HP $40.84
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 44.50
  • HP 48.95
  • Support Level
  • ANIP $65.68
  • HP $15.36
  • Resistance Level
  • ANIP $68.18
  • HP $17.55
  • Average True Range (ATR)
  • ANIP 2.29
  • HP 0.69
  • MACD
  • ANIP -0.27
  • HP 0.13
  • Stochastic Oscillator
  • ANIP 13.00
  • HP 51.35

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About HP Helmerich & Payne Inc.

Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.

Share on Social Networks: